Welcome to our dedicated page for Ifabric news (Ticker: IFABF), a resource for investors and traders seeking the latest updates and insights on Ifabric stock.
iFabric Corp. reports developments in technology-enhanced apparel and intelligent fabrics through its wholly owned subsidiary Intelligent Fabric Technologies (North America) Inc. Company updates frequently cover medical apparel programs such as Doctor's Choice scrubs and Frontline scrubs, along with proprietary textile technologies including PROTX2 antimicrobial treatment, ecoPEL fluorine-free durable water repellent technology, and DryTX moisture management.
Recurring news also includes financial results, revenue outlooks, retailer program expansions, and new product categories that apply IFTNA technologies to performance apparel, footwear, bedding, and other finished goods. The company's public updates also reference brand and retail programs including Verzus All Apparel, Roots branded footwear, and the Coconut Grove subsidiary within iFabric's broader operating structure.
iFabric Corp. has engaged Independent Trading Group to provide market-making services on the Toronto Stock Exchange. This collaboration aims to enhance the liquidity and market presence of iFabric's shares, with services commencing on February 12, 2021. According to the Services Agreement, ITG will receive C$6,000 per month for an initial three-month term, followed by month-to-month renewals unless terminated with 30 days' notice. iFabric operates through subsidiaries providing performance and protective apparel, as well as ladies' intimate apparel.
iFabric Corp. announced a 5-year exclusive agreement with Beverly Hills Investments to distribute ProTX2 formulations in Africa. The deal ensures minimum annual purchases of US$2 million, US$4 million, and US$12 million over the first three years. IFTNA's AVguard, a proprietary anti-viral laundry additive, was recently donated to The Village Medical Centre in Johannesburg, promoting this partnership. The agreement aims to support health during the COVID-19 pandemic by providing effective anti-microbial solutions.
iFabric Corp. has donated the initial production of its AVguard anti-viral laundry additive to The Village Medical Centre in Johannesburg, South Africa. This product, incorporating the company's PROTX2 technology, shows over 99.9% effectiveness against SARS-CoV-2, highlighting its potential as a crucial tool in combating COVID-19 transmission. The donation is considered a stepping stone towards the product's official launch, aimed at markets with lower regulatory barriers. Dr. Paul Freinkel from The Village Medical Centre noted the significant benefits AVguard brings to healthcare practitioners.